I'd like to talk about contemporary researchers' more rigid and limited approach to combination therapy. This is the model whose many limitations I point out with the ridiculously long label "mini-T3-mono-combination" therapy. I'll go over some of the history behind this model, the source of the rigid ratios that we learned about in our series …

Continue reading The mini-T3-mono-combination therapy model vs NDT and others

Let's get to work together! How? It's easy to do on Facebook. Not on Facebook? Currently we're only set up for group interaction on Facebook, sorry. That's where we were "born" and where we are most active. But please don't run away! If you can't or won't join Facebook but still want to help using …

Continue reading Want to help? Join a Thyroid Patients Campaign Working Group

In contrast with a long list of over 70 medical research articles on low T3 syndrome that excluded thyroid patients, I have only found three (3) studies so far that included patients being treated for hypothyroidism. I'll reveal their treasures and disappointments in reverse date order: Somppi, 2017 Tevaarwerk, 2014 Wadwekar, 2004 Here's how many …

Continue reading Low T3 syndrome in thyroid therapy: THREE studies

Here, I'll use my own personal example to discuss a few dimensions of T3 monotherapy, which I envision as a "wheelchair." I'm drawing on the fictional analogy I developed in an earlier post, where I imagined thyroid disease like crippling foot disease. The therapy of 100% T4 can be seen like a walking stick or …

Continue reading Thyroid therapies: What my life is like in the T3-monotherapy wheelchair

Most studies of Low T3 syndrome (NTIS) routinely EXCLUDE thyroid patients. Sadly, our exclusion has become a research tradition. In this post, I lay out the landscape and extent of our exclusion from this valuable area of thyroid hormone health research. Everyone loses by our exclusion. Especially thyroid patients. Everyone has something to gain from …

Continue reading Thyroid patients are routinely excluded from low T3 syndrome (NTIS) research

In 2018, Ataoglu and colleagues confirmed and expanded our knowledge of "Low T3 syndrome." Despite a normalized TSH, a Low T3 is deadly not only in acute, critical illness, but in "chronic disease." To be specific, Low T3 is more deadly in some health conditions than others. What should be really shocking to many is …

Continue reading Ataoglu: Low T3 in critical illness is deadly, and adding high T4 is worse.

Seeing things visually might help clarify what thyroid therapy is like. Our thyroid hides in our neck and our hormones hide in every inch of our body. Nobody sees our thyroid gland distort, die, or shrivel. Nobody sees what fatigue feels like. Nobody sees organs suffering from lack of T3. Nobody sees how our pills …

Continue reading What if TSH levels were like shoe sizes, thyroid meds like mobility aids